Why worrisome coronavirus mutations may soon hit their limit
The novel coronavirus that sparked the ongoing COVID-19 pandemic will continue to evolve over time, but it may be running out of the type of worrisome tricks seen in mutations first sequenced in the United Kingdom, Brazil, and South Africa, Dr. Dhruv Khullar writes in The New Yorker.
All three variants are troubling because of a change to the "spike" protein that allows the virus to latch on to humans' ACE-2 receptor and enter human cells more easily, making it more transmissible. And the Brazilian and South African variants carry an additional mutation which diminishes the ability of antibodies to bind to and neutralize the virus, possibly rendering previous infection and vaccines less effective, Khullar writes. There is good news, though — at least in the eyes of Jason McLellan, a structural biologist at the University of Texas at Austin, who believes such mutations may be few and far between going forward.
"There's just not a lot of space for the spike to continue to change in ways that allow it to evade antibodies but still bind to its receptor," McLellan told Khullar. "Substitutions that allow the virus to resist antibodies will probably also decrease its affinity for ACE-2," he continued, adding that because the variants "have independently hit on the same mutations" it's likely "we're already seeing the limits of where the virus can go."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
McLellan expanded on his fairly hopeful outlook, telling Khullar that the virus will indeed keep mutating, but likely into a less lethal version. "This is what we think happened to viruses that cause the common cold," he said. "It probably caused a major illness in the past. Then it evolved to a place where it's less deadly." Read more at The New Yorker.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published